Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “ADAPTATION, OCULAR”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 523 records · Page 29Linked to original sources
PubMedDate not supplied

[Comparative studies of constant ocular potential and dark adaptation in patients taking glycerol ascorbate].

Examination of ocular constant potentials and darkness adaptation in the patients taking glycerol ascorbate has revealed that this hypotensive agent depressed the constant potentials in normal subjects, this manifesting by a drastic reduction of its darkness and light reaction. Simultaneous studies of darkness adaptation have shown it to be but slightly elevated or unchanged. The authors suppose that hyperosmotic stress induced by glycerol ascorbate involves the pigmented epithelium, a constant potential generator.

Adolescent↗
PubMed1993

Ocular regression conceals adaptive progression of the visual system in a blind subterranean mammal.

The mole rat, Spalax ehrenberghi, is an extreme example of natural visual degeneration in mammals: visual pathways are regressed and incomplete, and the absence of visual cortical potentials or an overt behavioural response to light have led to the conclusion that Spalax is completely blind. But structural and molecular investigations of the atrophied, subcutaneous eye suggest a functional role for the retina in light perception, and entrainment of circadian locomotor and thermoregulatory rhythms by ambient light demonstrates a capacity for photoperiodic detection. We report here that severe regression of thalamic and tectal structures involved in form and motion perception is coupled to a selective hypertrophy of structures subserving photoperiodic functions. As an alternative to the prevalent view that ocular regression results from negative or nonselective evolutionary processes, the differential reduction and expansion of visual structures in Spalax can be explained as an adaptive response to the underground environment.

Adaptation, Physiological↗
PubMed2006

Adaptation of homeostatic ocular surface epithelium to chronic treatment with the opioid antagonist naltrexone.

PURPOSE: To determine how ocular surface epithelium adjusts to an increase in cell replication after treatment with the opioid antagonist naltrexone (NTX). METHODS: Adult male rats were given twice daily injections of 30 mg/kg NTX or vehicle for 7 days. Outcomes of NTX administration included DNA synthesis (monitored with BrdU), mitosis (assayed using colchicine), number of cell layers and cell diameter, apoptosis and necrosis, and packing density for the peripheral corneal epithelium, limbus, and conjunctiva. Also, transit time from basal to surface epithelial layers in the peripheral cornea was assessed with [H]thymidine as a marker. RESULTS: DNA synthesis and mitosis in the basal layer of the peripheral corneal epithelium of NTX-treated rats were increased 69% and 85%, respectively, from control levels; no changes in either parameter were recorded in the limbal or conjunctival epithelium (stem cell region). Epithelial thicknesses in the NTX group were increased by 8% to 38% from control subjects, without more cell layers. Packing density in NTX-treated rats was increased from control values by 26% in the basal layer of the limbus and by 12% to 28% in the suprabasal layers of the corneal epithelium, limbus, and conjunctiva. Epithelial cell diameters from corneas of NTX-exposed rats were subnormal in the basal and suprabasal cells of the limbus and conjunctiva. Apoptosis and necrosis were negligible in the epithelium of NTX-treated and control rats. Transit times of peripheral corneal epithelial cells of animals in the NTX group were shortened by 63% from control levels. CONCLUSIONS: These data show that a 1-week treatment with NTX does not induce proliferative pathology or toxicity in ocular surface epithelium, has a minimal effect on stem cell proliferation, and accelerates normal homeostatic processes. Topical application of NTX for stimulation of corneal epithelial wound healing results in no adverse sequelae, thereby supporting the therapeutic role for this drug in the treatment of ocular surface abnormalities.

Animals↗